The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. - Wikidata - wikimedia - TriplyDB

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

http://www.wikidata.org/entity/Q34462070

about

Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes Antithrombotic drugs for secondary stroke prophylaxis Antiplatelet agents for secondary prevention of ischemic stroke Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction Ischemic stroke prevention: an update on antiplatelet therapy Antithrombotic drugs in secondary stroke prevention among a community dwelling older population High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke Antiplatelet therapy in populations at high risk of atherothrombosis Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patient The PRoFESS trial: future impact on secondary stroke prevention Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: case report and literature review Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.The Secondary Prevention of Small Subcortical Strokes (SPS3) study.Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.Clopidogrel desensitization: case report and review of published protocols.Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).Ticlopidine and fatal aplastic anemia in an elderly woman.Fatal neutropenia and thrombocytopenia associated with ticlopidine.Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.Current management of ischaemic stroke.Antiplatelet therapy--Part II Ticlopidine hydrochloride and prevention of stroke.Ticlopidine hydrochloride use and threatened stroke.Antiplatelet therapy for secondary stroke prevention.Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis.North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.Antiplatelet use in interventional cardiology.Subcortical vascular dementia as a specific target for clinical trials.Aggrenox: a fixed-dose combination of aspirin and dipyridamole.Stroke: management and rehabilitation. Part III of III.Diabetes and vascular disease.

P2860

Q24203035-E4D1FCF5-27AA-4F0E-9DF7-DA96775C10A2 Q24646522-AE29D46D-66C1-4BD7-9947-C425767209FD Q28076042-783DA300-D4D5-43C2-9D8F-5CFF4597B764 Q28167896-D12FB6A3-4B3D-4A45-8EFE-F47219EFAE05 Q28182045-2F9ABCFD-EDCF-4D84-9AE7-02BC2522A266 Q28190669-606B7D91-65C6-42FB-9E7F-8261F4241CCB Q28192470-1F177A88-772D-4633-A73B-5DF005B40893 Q28192692-CF408A3B-7D76-40B2-99ED-0D91D64148F5 Q28193224-D9F553D9-A79E-4BC4-AFB0-E814EEC2C00E Q28196830-A08AE596-D264-4BA8-9803-457BCEA8B98D Q28208711-61D3BBA7-FF68-4F82-8456-211130361251 Q28211452-A5444D15-0AD2-4186-BAEE-5668D32A1084 Q28218702-A9688C67-C2B0-4D6C-A459-07981D47CA83 Q28219951-75F1330F-9F02-41EB-B1E1-3726D610B344 Q28221589-A288FDC9-706B-4A3A-B2FE-1A5E412F9E11 Q28221595-AF6B09D4-9AD4-4F57-BCE4-C99FF36FF36F Q28368089-C82DED60-4984-4BF8-9400-14C431EF89E2 Q29619529-62D3CBD5-104D-47B4-BDE0-FDCC518A2EAB Q30438893-F5DED01A-9622-4988-A6B2-6B6E6E5F112D Q30596571-AE82B045-B5AF-4705-A8F8-DFFC85AADBDF Q33335969-9BEE6050-6C4A-4DAA-BBDC-F255E98ABC34 Q33344214-61F0D9E7-7923-464D-81C3-1C210A9D6578 Q33378440-62AC1520-79A8-4C76-B717-E04CACA92CFD Q33404125-166BF0F0-45A0-4D4C-8260-A1017CC85C2A Q33490299-39FA5BA6-4124-49AC-BC9C-B7D627CEE658 Q33490373-405D2D52-01C8-4146-8FE6-00E6C0F9BA32 Q33581032-DD0ED7C4-3820-4E3D-9539-B703D5B8E033 Q33590385-554AFFF1-A208-4500-91EE-2528C8EEB35E Q33606997-1A42C1EC-64F1-4060-92C2-40B85D75F24A Q33607165-3B550AD3-B0B7-4793-9398-A000B4362180 Q33607265-8871AC4B-3688-4F47-BE03-06445FF47B6D Q33660954-105AA97B-4335-4768-BFD7-FF3D6095FA8A Q33727851-B8AD88BA-BDA6-45B3-805B-F4FCC0DA7F54 Q33789869-E2BC7AAA-054D-4B69-9878-51F86C1D5BE9 Q33810226-93E1E6E0-6DD9-4ABA-B43C-737ABF1DA8F4 Q33822508-5A3F4D25-5411-4FE1-82D2-22463A49A830 Q33922744-2A145737-D128-4EAF-B42F-0B5B625E27E0 Q34093604-CCD6F2F4-03CC-47B4-AEBD-36E8185CC187 Q34116128-7D378B7C-ACBE-4B1C-869A-5BA867680635 Q34157753-EF3EBF99-4942-42C8-A2BE-E921B7E287AC

P2860

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

http://www.wikidata.org/entity/Q34462070

description

1989 nî lūn-bûn

@nan

1989 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@ast

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@en

The Canadian American Ticlopidine Study

@nl

type

label

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@ast

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@en

The Canadian American Ticlopidine Study

@nl

prefLabel

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@ast

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@en

The Canadian American Ticlopidine Study

@nl

P1433

Q34462070-B66C361D-644D-4DF5-B5F6-7B18B6F3F294

P1476

Q34462070-47D682F7-915F-4E1B-982C-01B880413E66

P2093

Q34462070-18783FDC-BE94-4391-94C4-093B715B74E7

Q34462070-30838C8D-252D-491B-9BFD-9E7229325BB6

Q34462070-32ACE82D-0F1C-470C-BD4F-FE657134805A

Q34462070-3D69836C-8B52-4E47-96B7-359B4BA69652

Q34462070-5351DC3A-F723-4015-8FF3-E48B2EF75163

Q34462070-60781C6E-E189-46E7-B29A-041C6D8B669B

Q34462070-8F276553-4A77-4569-ACC7-26F7C4DACC26

Q34462070-AEFA89C1-7856-4C06-960B-317101D768C6

Q34462070-D2A14F08-C0BD-4866-9624-D52409B58ECB

Q34462070-E2A3655A-7C5A-4262-9C45-5CC116EBDBFB

P304

Q34462070-31E38BE3-1844-4110-BF14-58BA2D598C6C

P31

Q34462070-E0329A61-BDCA-452B-A53B-E79104DD8AFF

P356

Q34462070-8CF9A1A5-B475-4B1C-9AEC-A13791D88268

P407

Q34462070-D09EDA0A-E287-460E-86B7-49E64D7EEBFF

P433

Q34462070-19B317E5-5F53-49A1-AED7-B68A52A8750F

P478

Q34462070-46F350F4-8EA3-4BE3-8B01-F195E2A26DDE

P577

Q34462070-669EE952-538D-40E4-9367-117316300E2B

P698

Q34462070-49F7CA23-1F5A-418E-BF66-8259978B20B6

P921

Q34462070-17B77211-A5E0-4836-B2E0-8B3754B2799C

P356

S0140-6736(89)92327-1

P1433

P1476

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.

@en

P2093

A G Turpie

http://www.w3.org/2001/XMLSchema#string

D J Ellis

http://www.w3.org/2001/XMLSchema#string

E Panak

http://www.w3.org/2001/XMLSchema#string

J A Blakely

http://www.w3.org/2001/XMLSchema#string

J D Easton

http://www.w3.org/2001/XMLSchema#string

J Sicurella

http://www.w3.org/2001/XMLSchema#string

J W Harbison

http://www.w3.org/2001/XMLSchema#string

M Gent

http://www.w3.org/2001/XMLSchema#string

R S Roberts

http://www.w3.org/2001/XMLSchema#string

V C Hachinski

http://www.w3.org/2001/XMLSchema#string

P304

1215-1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(89)92327-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

8649

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

1989-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2566778

http://www.w3.org/2001/XMLSchema#string

P921

thromboembolism